Anti-VEGF drug

DRUG3 trials

Sponsors

Xiaodong Sun, Alexandria University, First Affiliated Hospital of Chongqing Medical University

Conditions

Center-involved Diabetic Macular EdemaDiabetic Macular EdemaPolypoidal Choroidal VasculopathyRetinal Vein Occlusion (RVO)

Phase 2

Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema

RecruitingNCT06845163

Alexandria UniversityCenter-involved Diabetic Macular Edema, Diabetic Macular Edema

Start: 2025-02-08End: 2026-08-31Target: 56Updated: 2025-06-19

Phase 4

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Xiaodong SunPolypoidal Choroidal Vasculopathy

Start: 2020-06-30End: 2022-09-30Target: 102Updated: 2020-05-08

Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment

RecruitingNCT07133438

First Affiliated Hospital of Chongqing Medical UniversityRetinal Vein Occlusion (RVO)

Start: 2025-08-01End: 2027-07-31Target: 120Updated: 2026-02-27

Related Papers

Adjuvant mecobalamin for anti-VEGF therapy in retinal vein occlusion: protocol of a single-centre, randomised, double-blinded controlled trial.

2026-07-22